Skip to main content
Pfizer COVID-19 vaccine appointments are available to our patients.
Sign up for Connect today
to schedule your vaccination.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Joint Clinical Trials Office
Explore this Website
Home
About
Toggle About menu options
News
JCTO Contacts
Careers
Our Clinical Trial Locations
Partner with the JCTO
Toggle Partner with the JCTO menu options
JCTO Fees
Open Clinical Trials
Investigators
Patients
Toggle Patients menu options
What is a Clinical Trial?
Frequently Asked Questions
Clinical Trial Questions to Ask Your Healthcare Team
Clinical Trials: Common Terms to Know
Understanding Clinical Trials and How They Work
Understanding Clinical Trials - In Spanish | En Español
Weill Cornell Medicine
Care
Discover
Teach
Home
About
Open Clinical Trials
Investigators
Patients
Home
Clinical Trials
An Extension Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects with Polycythemia Vera
Study Status:
Open to Enrollment
Primary Investigator:
Date:
June 17, 2024
A Phase 1/2, Multicenter, Open-Label, Randomized Dose Ranging and Expansion Study of the Combination of Gilteritinib, Venetoclax & Azacitidine in Patients with Newly Diagnosed FLT3 Mutated Acute Myeloid Leukemia not Eligible for Intensive Induction Chemo
Study Status:
Open to Enrollment
Primary Investigator:
Date:
June 25, 2024
Post-transplant NASH protocol to assess the development of metabolic comorbidities and disease recurrence in those transplanted for NASH cirrhosis
Study Status:
Open to Enrollment
Primary Investigator:
Date:
June 25, 2024
Phase Ib/III, Open-label, Randomised Study of Capivasertib plus CDK4/6 Inhibitors & Fulvestrant vs CDK4/6 Inhibitors & Fulvestrant in HR+ & Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date:
July 1, 2024
A Modular Phase I/II, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of AZD9829 as Monotherapy or in Combination in Patients with CD123-Positive Hematological Malignancies
Study Status:
Open to Enrollment
Primary Investigator:
Date:
July 1, 2024
Assessment of Colonic Oxygenation Utilizing Intra.OxTM
Study Status:
Open to Enrollment
Primary Investigator:
Date:
July 11, 2024
A Prospective, Multicenter, Randomized Clinical Investigation Evaluating GATT-Patch for Hemostasis during Minimally Invasive Liver and Gallbladder Surgery
Study Status:
Open to Enrollment
Primary Investigator:
Date:
July 11, 2024
Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial (COSMID)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
July 11, 2024
A Safety and Effectiveness Prospective Blinded clinical study to validate xBar system as monitoring tool for anastomotic leaks detection
Study Status:
Open to Enrollment
Primary Investigator:
Date:
July 11, 2024
An Open-Label, Single-Center, Investigator Initiated Phase 1B Trial of E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Study Status:
Open to Enrollment
Primary Investigator:
Date:
July 11, 2024
« first
‹ previous
…
19
20
21
22
23
(current)
24
25
26
27
next ›
last »